Functional cell types derived from human pluripotent stem cells are a significant advance for studying complex environment/gene interactions in disease and modelling congenital and acquired disease states. This provides a powerful approach to study these pathologies and discover novel drugs. We are using hPSCs to develop models of cardiovascular disease with a particular focus on ischemic and diabetic cardiomyopathy.

Project members

Key contacts

Dr Nathan Palpant

Group Leader, Genomics of Development and Disease Division
Senior Research Fellow - GL
Institute for Molecular Bioscience